Adenosine-A1 receptor agonist induced hyperalgesic priming type II
- PMID: 26588695
- PMCID: PMC5048916
- DOI: 10.1097/j.pain.0000000000000421
Adenosine-A1 receptor agonist induced hyperalgesic priming type II
Abstract
We have recently shown that repeated exposure of the peripheral terminal of the primary afferent nociceptor to the mu-opioid receptor (MOR) agonist DAMGO ([D-Ala, N-Me-Phe, Gly-ol]-enkephalin acetate salt) induces a model of transition to chronic pain that we have termed type II hyperalgesic priming. Similar to type I hyperalgesic priming, there is a markedly prolonged response to subsequent administration of proalgesic cytokines, prototypically prostaglandin E2 (PGE2). However, type II hyperalgesic priming differs from type I in being rapidly induced, protein kinase A (PKA), rather than PKCε dependent, not reversed by a protein translation inhibitor, occurring in female as well as in male rats, and isolectin B4-negative neuron dependent. We report that, as with the repeated injection of a MOR agonist, the repeated administration of an agonist at the A1-adenosine receptor, also a Gi-protein coupled receptor, N-cyclopentyladenosine (CPA), also produces priming similar to DAMGO-induced type II hyperalgesic priming. In this study, we demonstrate that priming induced by repeated exposure to this A1-adenosine receptor agonist shares the same mechanisms, as MOR-agonist induced priming. However, the prolongation of PGE2 hyperalgesia induced by repeated administration of CPA depends on G-protein αi subunit activation, differently from DAMGO-induced type II priming, in which it depends on the β/γ subunit. These data implicate a novel form of Gi-protein signaling pathway in the type II hyperalgesic priming induced by repeated administration of an agonist at A1-adenosine receptor to the peripheral terminal of the nociceptor.
Figures








Similar articles
-
Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.J Neurosci. 2015 Sep 9;35(36):12502-17. doi: 10.1523/JNEUROSCI.1673-15.2015. J Neurosci. 2015. PMID: 26354917 Free PMC article.
-
Hyperalgesic priming (type II) induced by repeated opioid exposure: maintenance mechanisms.Pain. 2017 Jul;158(7):1204-1216. doi: 10.1097/j.pain.0000000000000898. Pain. 2017. PMID: 28306605 Free PMC article.
-
Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming.Pain. 2016 Aug;157(8):1773-1782. doi: 10.1097/j.pain.0000000000000581. Pain. 2016. PMID: 27075428 Free PMC article.
-
Role of GPCR (mu-opioid)-receptor tyrosine kinase (epidermal growth factor) crosstalk in opioid-induced hyperalgesic priming (type II).Pain. 2018 May;159(5):864-875. doi: 10.1097/j.pain.0000000000001155. Pain. 2018. PMID: 29447132 Free PMC article.
-
Hyperalgesic Priming in the Transition From Acute to Chronic Pain: Focus on Different Models and the Molecular Mechanisms Involved.J Pain Res. 2025 Mar 21;18:1491-1501. doi: 10.2147/JPR.S514851. eCollection 2025. J Pain Res. 2025. PMID: 40135188 Free PMC article. Review.
Cited by
-
Systemic Morphine Produces Dose-dependent Nociceptor-mediated Biphasic Changes in Nociceptive Threshold and Neuroplasticity.Neuroscience. 2019 Feb 1;398:64-75. doi: 10.1016/j.neuroscience.2018.11.051. Epub 2018 Dec 7. Neuroscience. 2019. PMID: 30529265 Free PMC article.
-
Inhibitory Gi/O-coupled receptors in somatosensory neurons: Potential therapeutic targets for novel analgesics.Mol Pain. 2018 Jan-Dec;14:1744806918763646. doi: 10.1177/1744806918763646. Mol Pain. 2018. PMID: 29580154 Free PMC article. Review.
-
SDF1-CXCR4 Signaling Contributes to the Transition from Acute to Chronic Pain State.Mol Neurobiol. 2017 May;54(4):2763-2775. doi: 10.1007/s12035-016-9875-5. Epub 2016 Mar 24. Mol Neurobiol. 2017. PMID: 27011380
-
Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming.J Neurosci. 2019 Aug 14;39(33):6414-6424. doi: 10.1523/JNEUROSCI.0966-19.2019. Epub 2019 Jun 17. J Neurosci. 2019. PMID: 31209174 Free PMC article.
-
Electroacupuncture Regulates Pain Transition Through Inhibiting PKCε and TRPV1 Expression in Dorsal Root Ganglion.Front Neurosci. 2021 Jul 20;15:685715. doi: 10.3389/fnins.2021.685715. eCollection 2021. Front Neurosci. 2021. PMID: 34354561 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials